Qianhong-li
Qianhong Li, MD, Ph.D, FAHA
Associate Professor of Medicine

Department of Medicine
University of Louisville
Louisville, Kentucky, USA
Phone: (502) 852‐2463
Email: qhli0001@louisville.edu

Education

1979 – 1984 M.D. in Clinical Medicine, Xinjiang Medical College, Urumqi, Xinjiang, China
1984 – 1986 Clinical Physician in Department of Internal Medicine, The Second Affiliated Hospital of Xinjiang Medical College, Urumqi, Xinjiang, China
1986 – 1989 Master Degree in Cardiovascular Physiology, Xinjiang Medical College, Urumqi, Xinjiang, China
1992 – 1995 Ph.D. in Cardiovascular Molecular Biology, Beijing Medical University, Beijing, China
1996 – 1999 Postdoctoral Fellow in Molecular Cardiology, Division of Cardiovascular Medicine, Department of Medicine, University of Louisville, Louisville, KY

Biography

Dr. Li is an Associate Professor of Medicine in the Division of Cardiovascular Medicine, Department of Medicine, at the University of Louisville. She is a Director of Stem Cell and Pathology Core at the same university and Director of Biomarker Core in the NIH CAESAR. In these capacities, she has been directing two vigorous research laboratories and investigating the mechanisms responsible for myocardial ischemia/reperfusion injury and developing the cardioprotective strategies in the fields of gene therapy and cell therapy for 20 years. Dr. Li is a recipient of two NIH grants and several regional grants. She has been a member of the Council on Basic Cardiovascular Sciences of the American Heart Association (AHA), of the International Society for Heart Research, and of the American Society of Gene & Cell Therapy for many years. She is an international mentor in cardiovascular field elected by the American Heart Association. She has also served as a national and international peer reviewer for several extramural-national grant review panels and for highly impact journals including Circulation, Circulation Research, Hypertension, Journal of Clinical Investigation, Journal of Molecular and Cellular Cardiology, Journal of Cellular and Molecular Medicine, American Journal of Physiology, Molecular and Cellular Biochemistry, Basic Research in Cardiology, PLOS ONE, and Cell Cycle. In 2011, Dr. Li was elected as the Fellow of the national AHA (FAHA) because of her major and productive contributions in cardiovascular basic sciences. Combining the powers of molecular biology and gene transfer with the regenerative capacity of stem cells, Dr. Li and her associates are exploring the potentiation and mechanisms of adult cardiac progenitor cells to repair damaged myocardium. As a pioneer in this area, Dr. Li has created and established an adult cardiac progenitor cell system in the mouse. So far, this system has more than 30 adult cardiac progenitor cell populations and been funded by the NIH. 

Research Interest

  • Adult cardiac progenitor cell therapy for myocardial reparation
  • Gene therapy for myocardial injury
  • Molecular mechanisms of ischemia and reperfusion injury
  • Ischemic preconditioning in myocardium
  • Protection of ischemic myocardium 

SCIENTIFIC ACTIVITY

ACADEMIC APPOINTMENTS
1999 – 2002 Instructor of Medicine, Division of Cardiovascular Medicine, Department of Medicine, University of Louisville, Louisville, KY
2002 – 2012 Assistant Professor of Medicine, Division of Cardiovascular Medicine, Department of Medicine, University of Louisville, Louisville, KY
2005 – present Director, Gene Therapy Core, Institute of Molecular Cardiology, University of Louisville, Louisville, KY
2009 – present Director, Stem Cell and Pathology Core, Institute of Molecular Cardiology,University of Louisville, Louisville, KY
2010 – present Director, Biomarker Core of NIH CAESAR, Institute of Molecular Cardiology, University of Louisville, Louisville, KY
2012 – present Associate Professor of Medicine, Division of Cardiovascular Medicine, Department of Medicine, University of Louisville, Louisville, KY

OTHER POSITIONS AND EMPLOYMENT
1989 – 1992 Instructor and Lecture, Department of Physiology, Nanjing Railway Medical College, Nanjing, Jiangsu, China
1992 – 1996 Director, Committee of Graduate Affairs, Cardiovascular Institute, Beijing Medical University, Beijing, China
1994 – 1996 Supervisor of Graduate Student, Cardiovascular Institute, Beijing Medical University, Beijing, China
1995 – 1996 Instructor and Lecturer, Cardiovascular Institute, Beijing Medical University, Beijing, China
2006 – 2009 International Cardiovascular Mentor, American Heart Association, Dallas, TX
2011 – present International Cardiovascular Mentor, American Heart Association, Dallas, TX
2011 – present FAHA (Fellow of the American Heart Association), Basic Cardiovascular Sciences Council, American Heart Association, Dallas, TX

HONOURS AND AWARDS
1997 The First Place Award ($500) for Major Potential for Clinical Application in Gene Therapy at the Research!Louisville Competition sponsored by the Jewish Hospital Foundation, Louisville, KY
1997 The Third Place Award ($300) for Originality Study in Gene Therapy at the Research!Louisville Competition sponsored by the Jewish Hospital Foundation, Louisville, KY
1998 The First Place Award ($500) for Major Basic Research Application in Gene Therapy at the Research!Louisville Competition sponsored by the Jewish, Hospital Foundation, Louisville, KY
1998 The First Place Award ($500) for Scientific Importance in Gene Therapy at the Research!Louisville Competition sponsored by the Jewish Hospital Foundation, Louisville, KY
1999-2001 American Heart Association Fellowship ($60,000) Project: "Molecular regulation of iNOS gene expression during late preconditioning in mice"
2014 Annual Award of Outstanding Basic Faculty Division of Cardiovascular Medicine, Department of Medicine, University of Louisville, Louisville, KY

Publications

  1. Li Q, Ju D. Effects of arsenic on functions of circulation and respiration. Foreign Medicine (Health Section). 13(3): 49‐52, 1989.
  2. Li Q, Ju D. Some physiological effects of arsenic on papillary muscle of heart in rabbit. Endemic Diseases Bulletin. 6(1):27‐30, 1991.
  3.  Wang J, Li Q, Dong WJ, Chen JS. Effects of various noise exposures on endocochlear potentials correlated with cochlear gross responses. Hearing Research. 59:31‐38, PMID: 1629044, 1992 (Cited 6 times).
  4. Wang J, Li Q, Dong W, Chen J. Changes in endocochlear potential induced by potassium‐channel blockers. Acta Physiologica Sinica. 45(1):69‐74, 1992.
  5. Wang J, Li Q, Dong W, Chen J. Changes in cochlear potentials induced by brief exposure to intense noise. Chinese J. Appl. Physiol. 8(1):37‐41, 1992.
  6. Wang J, Li Q, Chen J. Calcium and function of hair cell in endocochlea. Physiol Sci Progress. 23(2):145‐149, 1992.
  7. Wang J, Li Q, Dong W, Chen J. Changes in endocochlear potentials induced by noise at different intensities and the possible mechanism underlying. J. Nanjing Railway Medical College. 11(4):193‐ 196, 1992.
  8. Wang J, Li QH, Dong WJ, Chen JS. Effects of K(+)‐channel blockers on cochlear potentials in the guinea pig. Hearing Research. 68(2):152‐158, PMID: 8407601, 1993 (Cited 14 times).
  9. Wang J, Li Q, Dong W, Chen J. Preliminary investigation of mechanism underlying effect of oxytocin on endocochlear potential. Chinese J. Appl. Physiol. 9(1):13‐15, 1993.
  10. Yang YD, Li Q, Zhang XB. Advances in identifying the genes relating to essential hypertension (I). Chin J. Hypertension. 11(1):1‐4, 1993.
  11. Yang YD, Li Q, Zhang XB. Advances in identifying the genes relating to essential hypertension (II). Chin J. Hypertension. 1(2):69‐72, 1993.
  12. Li Q, Zhang CH, Zhang LZ, Zhang XB, Zhou AR, Tang J. Expression and distribution of nitric oxide synthase mRNA in central and peripheral tissues. Chin J Hypertension. 1(1):27‐30, 1993.
  13. Li Q, Tang J. Nitric oxide‐‐a novel message in cardiovascular system. Foreign Medicine (Physiology/ Pathophysiology Section). 13(3):125‐128, 1993.
  14. Li Q, Tian Q, Gong CN, Zhao MQ, Zhang CH, Zhou H, Zhou AR, Tang J, Ma DD. Regulation and biological effects of endothelin and interleukin‐1 on expression of nitric oxide synthase gene in vascular smooth muscle cells. J Beijing Medical University. 26:9‐14, 1994.
  15. Li Q, Zhou H, Xu J, Tang J. Endothelium‐derived relaxing factor/nitric oxide and hypertension. Chinese Circulation J. 9(7):435‐437, 1994.
  16. Li Q, Tang J. Renin binding protein. Physiol Sci Progress (Sheng Li Ke Xue Jin Zhan). 25(3):253‐254, PMID: 7878443, 1994.
  17. Zhang CH, Li Q, Zhang JF, Zhou H, Zhang XB, Tang J. Semiquantitative detection and application about the expression of nitric oxide synthase gene. Acta Physiologica Sinica (Sheng Li Xue Bao). 46(4):347‐354, PMID: 7526470, 1994 (Cited 2 times).
  18. Zhang CH, Li Q, Zhou H, Zhang XB, Zhou AR, Tang J. Expression of endothelin A receptor gene in spontaneously hypertensive rats. Chin J Hypertension. 2(2):77‐79, 1994.
  19. Zhang XB, Huang HY, Zhang LZ, Li Q, Zhang CH, Tang J. Measurement of nitric oxide synthase activity and its application. J Beijing Medical University. 26:173‐176, 1994.
  20. Zhou H, Zhang C, Li Q, Nui D, Tang J. Effect of endothelin on expression of nitric oxide synthase gene of vascular smooth muscle. Chinese J. Hypertension. 2(2):75‐77, 1994.
  21. Zhou H, Zhang C, Li Q, Nui D, Zhang X, Zhou A, Wei J, Tang J. Expression of endothelin A receptor gene in cardiovascular cells of rat. Chinese Sci. Bulletin. 39(12):1137‐1140, 1994.
  22. Li Q, Zhang C, Wei J, Tang J, Zhou A. Expression of angiotensin II type‐1 receptor gene in Spontaneously hypertensive rat. J Beijing Medical University. 26:40‐44, 1994.
  23. Wei YJ, Tian Q, Li QH, Li YL, Chang JK, Tang J, Ho SY. Hemodynamic effects of centrally administered adrenomedullin (13‐52) in anesthetized rats. Biol Signals (Engl). 4(6):338‐344, PMID: 8688913, 1995 (Cited 5 times).
  24. Tian Q, Li Q, Song L. Zhang Z, Wei YJ, Tang J. Studies on adrenomedullin: a novel hypotensive peptide. Chin Med J (Engl). 108(10):781‐782, PMID: 8565667, 1995.
  25. Tian Q, Zhao D, Tan DY, Zhao YT, Li Q, Qiu JX, Song LW, Gong CN, Yang J, Lippton H, Hyman AL, Tang J, Chang JK. Vascular effect of human adrenomedullin (13‐52) on hypertensive rats. Canadian J Physiol Pharmacol. 73:1065‐1069, 1995.
  26. Wei YJ, Li Q, Song L, Zhao D, Zhang Z, He R, Tang J. The central distribution of adrenomedullin and its effects on blood pressure and heart rate in rats. Chin Med Sci J (Engl). 11(1):1‐7, PMID: 9206109, 1996 (Cited 14 times).
  27. Wei YJ, Ouyang D, Li Q, Chang JK, He R, Tang J. Effect of centrally administered adrenomedullin on cardiovascular system and the correspondent mechanisms. Chin J. Hypertension. 4(1):11‐14, 1996 (in English).
  28. Li Q, Song LW, Ouyang D, Wei YJ, Zhou AR, Tang J. A procedure for in situ RT‐PCR amplification of nitric oxide synthase mRNA on histological specimens. Chin J. Hypertension. 4(1):15‐18, 1996 (in English).
  29. Li Q, Murphree SS, Willer SS, Bolli R, French BA. Gene therapy with bilirubin UDP‐glucuronosyltransferase in the Gunn rat model of Crigler‐Najjar syndrome type I. Human Gene Therapy. 9(4):497‐505, PMID: 9525311, 1998 (Cited 32 times).
  30. Li Q, Bolli R, Qiu Y, Tang XL, Murphree SS, French BA. Gene therapy with extracellular superoxide dismutase alleviates myocardial stunning in conscious rabbits. Circulation. 98:1438‐1448, PMID: 9760299, 1998 (Cited 102 times).
  31.  Li Q, Bolli R, Qiu Y, Tang XL, Guo YR, French BA. Gene therapy with extracellular superoxide dismutase protects conscious rabbits against myocardial infarction. Circulation. 103:1893‐1898, PMID: 11294809, 2001 (Cited 144 times).
  32. Li Q, Guo Y, Xuan YT, Lowenstein CJ, Stevenson SC, Prabhu SD, Wu WJ, Zhu Y, Bolli R. Gene therapy with inducible nitric oxide synthase protects against myocardial infarction via a cyclooxygenase‐2‐ dependent mechanism. Circ Res. 92(7):741‐748, PMID: 12702642, 2003 (Cited by 104).
  33. Guo Y, Stein AB, Wu WJ, Tan W, Zhu X, Li Q, Dawn B, Motterlini R, Bolli R. Administration of a COreleasing molecule at the time of reperfusion reduces infarct size in vivo. Am J Physiol Heart Circ Physiol. 286(5):H1649‐1653, PMID: 14704226, 2004 (Cited by 179).
  34. Stein AB, Guo Y, Tan W, Wu WJ, Zhu X, Li Q, Luo C, Dawn B, Johnson TR, Motterlini R, Bolli R. Administration of a CO‐releasing molecule induces late preconditioning against myocardial infarction. J Mol Cell Cardiol. 38(1):127‐134, PMID: 15623429, 2005 (Cited by 92).
  35. Guo Y, Stein AB, Wu WJ, Zhu X, Tan W, Li Q, Bolli R. Late preconditioning induced by NO donors, adenosine A1 receptor agonists, and {delta}1‐opioid receptor agonists is mediated by iNOS. Am J Physiol Heart Circ Physiol. 289(5):H2251‐H2257, PMID: 16006548, 2005 (Cited by 65).
  36. Li Q, Guo Y, Tan W, Stein AB, Dawn B, Wu WJ, Zhu X, Lu X, Xu X, Siddiqui T, Tiwari S, Bolli R. Gene therapy with inducible nitric oxide synthase provides long‐term protection against myocardial infarction without adverse functional consequences. Am J Physiol Heart Circ Physiol. 290(2):H584‐H589, PMID: 16172153, 2006 (Cited by 44).
  37. Tang XL, Sato H, Tiwari S, Dawn B, Bi Q, Li Q, Shirk G, Bolli R. Cardioprotection by postconditioning in conscious rats is limited to coronary occlusions <45 min. Am J Physiol Heart Circ Physiol. 291(5):H2308‐H2317, PMID: 16815986, 2006 (Cited by 82).
  38. Bolli R, Li QH, Tang XL, Guo Y, Xuan YT, Rokosh G, Dawn B. The late phase of preconditioning and its natural clinical application‐gene therapy. Heart Fail Rev. 12(3‐4):189‐199, PMID: 17541820, 2007 (Cited by 62).
  39. Li Q, Guo Y, Tan W, Ou Q, Wu WJ, Sturza D, Dawn B, Hunt G, Cui C, Bolli R. Cardioprotection afforded by inducible nitric oxide synthase gene therapy is mediated by cyclooxygenase‐2 via a nuclear factor‐kappaB dependent pathway. Circulation. 116(14):1577‐1584, PMID: 17785622, 2007 (Cited by 59).
  40. Li Q, Guo Y, Tan W, Ou Q, Wu WJ, Sturza D, Dawn B, Hunt G, Cui C, Bolli R. Cardioprotection afforded by inducible nitric oxide synthase gene therapy is mediated by cyclooxygenase‐2 via a nuclear factor‐kappaB dependent pathway. Circulation. 116(14):1577‐1584, PMID: 17785622, 2007 (Cited by 59).
  41. Guo Y, Li Q, Wu WJ, Tan W, Zhu X, Mu J, Bolli R. Endothelial nitric oxide synthase is not necessary for the early phase of ischemic preconditioning in the mouse. J Mol Cell Cardiol. 44(3):496‐501, PMID: 18291412, 2008 (Cited by 29).
  42. Flaherty MP, Abdel‐Latif A, Li Q, Hunt G, Ranjan S, Ou Q, Tang XL, Johnson RK, Bolli R, and Dawn B. Noncanonical Wnt11 signaling is sufficient to induce cardiomyogenic differentiation in unfractionated bone marrow mononuclear cells. Circulation. 117(17):2241‐2252, PMID: 18427129, 2008 (Cited by 67)
  43. Li Q, Guo Y, Ou Q, Cui C, Wu W, Tan W, Zhu X, Lanceta L, Sanganalmath S, Dawn B, Shinmura K, Rokosh G, Wang S, Bolli R. Gene transfer of inducible nitric oxide synthase affordscardioprotection by upregulating heme oxygenase‐1 via an NF‐кB‐dependent pathway.Circulation. 120(13):1222‐1230, PMID: 19752329, 2009 (Cited by 37).
  44. Wang W, Hamid T, Keith RJ, Zhou G, Partridge CR, Xiang X, Kingery JR, Lewis RK, Li Q, Rokosh G, Ford R, Spinale FG, Riggs DW, Srivastava S, Bhatnagar A, Bolli R, Prabhu SD. Cardioprotective and anti‐apoptotic effects of heme oxygenase‐1 in the failing heart. Circulation. 121(17):1912‐1925, PMID: 20404253, 2010 (Cited by 133).
  45. Li Q, Guo Y, Ou Q, Chen N, Wu W, Yuan F, O'Brien E, Wang T, Luo L, Hunt G, Zhu X, Bolli R. Intracoronary administration of cardiac progenitor cells in mice: A new, improved technique for cell therapy in murine models. Basic Research in Cardiology. 106(5):849‐864, PMID: 21516491, 2011 (Cited by 62).
  46. Li Q, Guo Y, Wu W, Ou Q, Zhu X, Tan W, Yuan F, Chen N, Dawn B, Luo L, O’Brien EM, Bolli R. Gene transfer as a strategy to achieve permanent cardioprotection I: rAAV‐mediated gene therapy with inducible nitric oxide synthase limits infarct size 1 year later without adverse functional consequences. Basic Research in Cardiology. 106(6):1355‐1366, PMID: 21779912, 2011 (Cited by 17).
  47. Li Q, Guo Y, Ou Q, Wu W, Chen N, Zhu X, Tan W, Yuan F, Dawn B, Luo L, Hunt GN, Bolli R. Gene transfer as a strategy to achieve permanent cardioprotection II: rAAV‐mediated gene therapy with heme oxygenase‐1 limits infarct size 1 year later without adverse functional consequences. Basic Research in Cardiology. 106(6):1367‐1377, PMID: 21785893, 2011 (Cited by 20).
  48. Guo Y, Sanganalmath SK, Wu W, Zhu X, Huang Y, Tan W, Ildstad ST, Li Q, Bolli R. Identification of inducible nitric oxide synthase in peripheral blood cells as a mediator of myocardial ischemia/reperfusion injury. Basic Research in Cardiology. 107(2):253 ‐ (8 pages), Epub, PMID:22351077, 2012 (Cited by 16).
  49. Guo Y, Tukaye DN, Wu WJ, Zhu X, Tan W, Book M, Jones SP, Rokosh R, Narumiya S, Li Q, Bolli R.The COX‐2/PGI2 receptor axis plays an obligatory role in mediating the cardioprotection conferred by the late  hase of ischemic preconditioning". PLoS ONE. 7(7):e41178‐. Epub, PMID: 22844439, 2012 (Cited by 20).
  50. Guo Y, Flaherty MP, Wu WJ, Tan W, Zhu X, Li Q, Bolli R. Genetic background, gender, age, body temperature, and arterial blood pH have a major impact on myocardial infarct size in the mouse and need to be carefully measured and/or taken into account: results of a comprehensive analysis of determinants of infarct size in 1,074 mice. Basic Research in Cardiology. 107(5):288 ‐ (24 pages). Epub, PMID: 22864681, 2012 (Cited by 23).
  51. Cai C, Teng L, Vu D, He JQ, Guo Y, Li Q, Tang XL, Rokosh G, Bhatnagar A, Bolli R. The heme oxygenase 1 inducer (CoPP) protects human cardiac stem cells against apoptosis through activation of the ERK/Nrf2 signaling pathway and cytokine Release. J Biol Chem. 287 (40):33720‐33732, PMID: 22879597, 2012 (Cited by 30).
  52. Obal D, Dai S, Keith R, Dimova N, Kingery J, Zheng YT, Zweier J, Velayutham M, Prabhu SD, Li Q, Conklin D, Yang D, Bhatnagar A, Bolli R, Rokosh G. Cardiomyocyte‐restricted overexpression of extracellular superoxide dismutase increases nitric oxide bioavailability and reduces infarct size after ischemia/reperfusion. Basic Research in Cardiology. 107(6):305 – (14 pages). Epub, PMID: 23099819, 2012 (Cited by 20).
  53. Zafir A, Readnower R, Long BW, McCracken J, Aird A, Alvarez A, Cummins TD, Li Q, Hill BG, Bhatnagar A, Prabhu SD, Bolli R, Jones SP. Protein O‐GlcNAcylation is a novel cytoprotective signal in cardiac stem cells. Stem Cells. 31(4):765‐775, PMID: 23335157, 2013 (Cited by 23).
  54. Hong KU, Li Q, Guo Y, Patton NS, Moktar A, Bhatnagar A, Bolli R. A highly sensitive and accurate method to quantify absolute numbers of c‐kit+ cardiac stem cells following transplantation in mice. Basic Research in Cardiology. 108(3):346 – (10 pages). Epub, PMID: 23549981, 2013 (Cited by 33). Qianhong Li, MD, PhD, FAHA Updated October 21, 2016 Page 20 of 20.
  55. Hong KU, Guo Y, Li Q, Cao P, Al‐Maqtari T, Vajravelu BN, Du J, Book MJ, Zhu X, Nong Y, Bhatnagar A, Bolli R. c‐kit+ cardiac stem cells alleviate post‐myocardial infarction left ventricular dysfunction despite poor engraftment and negligible retention in the recipient heart. PLoS One. 9(5):e96725 (7 pages). doi: 10.1371/journal.pone.0096725, PMID: 24806457, 2014 (Cited by 29).
  56. Jones SP, Tang XL, Guo Y, Steenbergen C, Lefer DJ, Kukreja RC, Kong M, Li Q, Bhushan S, Zhu X, Du J, Nong Y, Stowers HL, Kondo K, Hunt GN, Goodchild TT, Orr A, Chang CC, Ockaili R, Salloum FN, Bolli R. The NHLBI‐sponsored Consortium for preclinicAl assESsment of cARdioprotective therapies (CAESAR): a new paradigm for rigorous, accurate, and reproducible evaluation of putative infarctsparing interventions in mice, rabbits, and pigs. Circ Res. 116(4):572‐586, PMID: 25499773, 2015 (Cited by 14).
  57.  Keith MCL, Tang XL, Tokita Y, Li Q, Ghafghazi S, Moore IV J, Hong KU, Elmore B, Amraotkar A, Ganzel BL, Grubb KJ, Flaherty MP, Hunt G, Vajravelu B, Wysoczynski M, Bolli R. Safety of intracoronary infusion of 20 million c‐kit positive human cardiac stem cells in pigs. PLoS One. Apr23; 10(4):e0124227. doi: 10.1371/journal.pone.0124227. eCollection PMID: 25905721, 2015 (Cited by 2).
  58. Zafir A, Bradley JA, Long BW, Muthusamy S, Li Q, Hill BG, Wysoczynski M, Prabhu SD, Bhatnagar A, Bolli R, Jones SP. O‐GlcNAcylation negatively regulates cardiomyogenic fate in adult mouse cardiac mesenchymal stromal cells. PLoS One. Nov 13; 10(11):e0142939. doi: 10.1371/journal.pone.0142939. eCollection PMID: 26565625, 2015.
  59. Cai C, Guo Y, Teng L, Nong Y, Tan M, Book MJ, Zhu X, Wang XL, Du J, Wu WJ, Xie W, Hong KU, Li Q,  Bolli R. Preconditioning human cardiac stem cells with an HO‐1 inducer exerts beneficial effects after cell transplantation in the infarcted murine Heart. Stem Cells. 33(12):3596‐3607. PMID: 26299779, 2015 (Cited by 1).
  60. Salabei JK, Lorkiewicz PK, Holden CR, Li Q, Hong KU, Bolli R, Bhatnagar A, Hill BG. Glutamine regulates cardiac progenitor cell metabolism and proliferation. Stem Cells. 33(8):2613‐2627. PMID: 25917428, 2015 (Cited by 1).
  61. Salabei JK, Lorkiewicz PK, Mehra P, Gibb AA, Haberzettl P, Hong KU, Wei X, Zhang X, Li Q, Wysoczynski M, Bolli R, Bhatnagar A, Hill BG. Type 2 diabetes dysregulates glucose metabolism in cardiac progenitor cells. J Biol Chem. 291(26):13634‐13648. PMID: 27151219, 2016.
  62. Tang XL*, Li Q*, Rokosh G, Sanganalmath SK, Chen N, Dawn B, Stowers H, Hunt G, Bolli R. Longterm outcome of administration of c‐kitPOS cardiac progenitor cells after acute myocardial infarction: transplanted cells do not become cardiomyocytes, but structural and functional improvement and proliferation of endogenous cells persist for at least one year. Circ Res. 118(7):1091‐1105. PMID: 26838790, 2016 (*equal contribution as first authors) (Cited by 2).
  63. Yukichi Tokita Y*, Tang XL*, Li Q*, Wysoczynski M, Hong KU, Bolli RA, Nakamura S, Wu WJ, Xie W, Li D, Hunt G, Ou Q, Stowers H, Bolli R. Repeated administrations of cardiac progenitor cells are markedly more effective than a single administration: a new paradigm in cell therapy. Circ Res. 119(5):635‐651. PMID: 27364016, 2016 (*equal contribution as first authors).
  64. Hamid T, Xu Y, Ismahil MA, Li Q, Jones SP, Bhatnagar A, Bolli R, Prabhu SD. TNF receptor signaling inhibits cardiomyogenic differentiation of cardiac stem cells and promotes a neuroadrenergic‐like fate. Am J Physiol Heart Circ Physiol. Sep 2:ajpheart.00904.2015. doi: 10.1152/ajpheart.00904.2015. [Epub ahead of print]. PMID: 27591224, 2016.

Heart Health Journal Flyer